Share
Market Research Report

ANTIPARASITIC DRUGS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2026-2033)

Segmentation
  • By Product TypeAnthelmintics (Anticestodal Drugs, Antitrematodal Drugs, and Antinematodal Drugs) Antiprotozoal Agents (Antimalarials Agents Antibabesial Agents, Antiamoebic Agents, and Others (Trypanocidal Agents, Antileishmanial Agents, etc.)) · Ectoparasiticide (Antiscabietic Agents and Pediculicides)
  • By Route Of AdministrationOral · Injectable · and Topical
  • Published In27 Apr 2026
  • Report CodeCMI3782
  • Pages250+
  • FormatsExcel and PDF
  • Base Year2025
  • Estimated Year2026
  • Historical Range2020 - 2024
  • Forecast Period2026-2033
  1. Research Objectives and Assumptions

    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview

    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snapshot, By Product Type
      • Market Snapshot, By Route Of Administration
      • Market Snapshot, By Application
      • Market Snapshot, By Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis

    • Market Dynamics
      • Drivers
      • Restraints
      • Market Attractiveness Analysis
      • Market Opportunities
      • Merger, Acquisition, Collaborations
      • Funding and Investment
      • Future Prospective of Antiparasitic Drugs 
      • Regulatory Guideline and Compliances
      • Key Developments
      • PEST Analysis
      • PORTER’s Analysis
  4. Global Antiparasitic Drugs Market, By Product Type, 2021–2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segment Trends
    • Anthelmintics
      • Anticestodal Drugs
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
      • Antitrematodal Drugs
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
      • Antinematodal Drugs
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Antiprotozoal Agents
      • Antimalarials Agents
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
      • Antibabesial Agents
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
      • Antiamoebic Agents
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
      • Others (Trypanocidal Agents, Antileishmanial Agents, etc.)
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Ectoparasiticide
      • Antiscabietic Agents
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
      • Pediculicides
        • Introduction
        • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  5. Global Antiparasitic Drugs Market, By Route of Administration, 2021 - 2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segments Trends
    • Oral
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Injectable
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Topical
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  6. Global Antiparasitic Drugs Market, By Application, 2021 – 2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, 2022 – 2033
      • Segments Trends
    • Human Health
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Animal Health
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
    • Crop Health
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2021–2033, (US$ Billion)
  7. Global Antiparasitic Drugs Market, By Region, 2021 – 2033, (US$ Billion)

    • Introduction
      • Market Share Analysis, By Region, 2026 and 2033 (%)
      • Y-o-Y Growth Analysis, For Region, 2022–2033
      • Regional Trends
    • North America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • U.S.
        • Canada
    • Latin America
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • Brazil
        • Mexico
        • Argentina
        • Rest of Latin America
    • Europe
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • U.K.
        • Germany
        • Italy
        • France
        • Spain
        • Russia
        • Rest of Europe
    • Asia Pacific
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • China
        • India
        • Japan
        • ASEAN
        • Australia
        • South Korea
        • Rest of Asia Pacific
    • Middle East
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country, 2021 – 2033, (US$ Billion)
        • GCC
        • Israel
        • Rest of Middle East
    • Africa
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Route of Administration, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Application, 2021 - 2033, (US$ Billion)
      • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2021 – 2033, (US$ Billion)
        • North Africa
        • Central Africa
        • South Africa
  8. Competitive Landscape

    • Merck KGaA
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • GlaxoSmithKline plc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cipla Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Cadila Pharmaceuticals
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Watson International Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Vivaldis
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Glenmark Pharmaceuticals Limited
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Advanced Bioscience Laboratories, Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Viatris Inc.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Novartis AG
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • AdvaCare Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Lupin
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Catalent, Inc
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Sun Pharmaceutical Industries Ltd.
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
    • Aurobindo Pharma
      • Company Highlights
      • Product Portfolio
      • Key Highlights
      • Financial Performance
      • Market Strategies
  9. Section

    • Research Methodology
    • About Us

*Browse 32 market data tables and 36 figures on “Global Antiparasitic Drugs Market”- Global forecast to 2033